Shun-Bing Shi
Shun-Bing Shi publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Hepatology, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment and Hepatocellular Carcinoma Treatment and Prognosis.
- World rank
- #5,337,018 of 7,710,434 ranked researchers
- Rank in China
- #783,758 of 978,568
- Works
- 17
- Citations
- 330
- Citations per work
- 19.4
What does Shun-Bing Shi research?
Shun-Bing Shi's work is mostly in Medicine (81%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1480.9%
- Medicine1480.9%
- Everything else212.7%
- Life Sciences16.4%
- 1Pulmonary and Respiratory Medicine47% of their works
- 2Oncology17% of their works
- 3Hepatology6% of their works
- 4Radiology, Nuclear Medicine and Imaging6% of their works
- 5Molecular Biology6% of their works
- 6Surgery4% of their works
Research topics
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Hepatocellular Carcinoma Treatment and Prognosis
- Drug Transport and Resistance Mechanisms
- Lung Cancer Research Studies
- Gastric Cancer Management and Outcomes
- Radiomics and Machine Learning in Medical Imaging
- Cholangiocarcinoma and Gallbladder Cancer Studies
Which keywords describe Shun-Bing Shi's research?
The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Chemotherapy, ALK Inhibitors, EGFR Mutations, Adjuvant Therapy, CT Screening and Lung Cancer.
- Small-Cell Lung Cancer
- Medical Imaging
- Gastric Cancer
- Cholangiocarcinoma
- Multidrug Resistance
- Hepatocellular Carcinoma
- Prognostic Factors
- Lung Cancer
- Adjuvant Therapy
- ALK Inhibitors
- Targeted Therapy
- Clinical Trials
- Chemotherapy
- EGFR Mutations
- CT Screening
- Clinical Practice Guidelines
- ATP-dependent Transporters
- Liver Cancer
- Biliary Tract Cancer
- Endoscopic Resection
- Genomic Profiles
- Radiomics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 22 words, with their numbers
- Clinical Trials132 topics
- Targeted Therapy132 topics
- Chemotherapy123 topics
- ALK Inhibitors111 topic
- EGFR Mutations111 topic
- Adjuvant Therapy102 topics
- CT Screening81 topic
- Lung Cancer81 topic
- Clinical Practice Guidelines52 topics
- Prognostic Factors42 topics
- ATP-dependent Transporters31 topic
- Hepatocellular Carcinoma31 topic
- Liver Cancer31 topic
- Multidrug Resistance31 topic
- Biliary Tract Cancer21 topic
- Cholangiocarcinoma21 topic
- Endoscopic Resection21 topic
- Gastric Cancer21 topic
- Genomic Profiles21 topic
- Medical Imaging21 topic
- Radiomics21 topic
- Small-Cell Lung Cancer21 topic
Where does Shun-Bing Shi work?
Shun-Bing Shi's main affiliation in the publication record is Jiangsu University, China.
How many publications and citations does Shun-Bing Shi have?
OpenAlex counts 17 works and 330 citations for Shun-Bing Shi, an h-index of 11, ranking #5,337,018 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Shun-Bing Shi. Posts are plain text and can be reported.